Singapore row over research ethics
Singapore’s dreams of becoming a world-class research hub for biotechnology are being tarnished by a dispute over the sacking of a UK scientist who used to head its National Neuroscience Institute. In 2002 Dr Simon Shorvon was accused of conducting tests without the proper consent of the patients involved and over whether ethics committees had been kept fully informed.
However, the UK-based Medical Protection Society has rejected all charges of professional misconduct on his behalf and three leading UK medical experts said that he acted ethically at all times. One of them, Professor Peter Sever, of Imperial College London, called upon the Royal College of Physicians to warn its members of the dangers of working in Singapore.
Biotechnology is a pillar of Singapore’s vision for its future and Singaporean bureaucrats are keen to maintain its professional reputation. “It is important that we get this right, that outsiders see us as a place beyond reproach, where international best practices are followed,” says Manu Bhaskaran, head of economic research for the Centennial Group.
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...